CIBC Private Wealth Group’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$16.4K Sell
202
-58
-22% -$4.99K ﹤0.01% 2243
2025
Q3
$22.8K Buy
260
+70
+37% +$6.25K ﹤0.01% 2108
2025
Q2
$15.8K Hold
190
﹤0.01% 2105
2025
Q1
$14.8K Hold
190
﹤0.01% 2099
2024
Q4
$18K Sell
190
-15
-7% -$1.44K ﹤0.01% 2101
2024
Q3
$19K Hold
205
﹤0.01% 2179
2024
Q2
$17K Sell
205
-197
-49% -$14.5K ﹤0.01% 2090
2024
Q1
$26.5K Buy
+402
New +$24.8K ﹤0.01% 1928
2018
Q1
Sell
-10,497
Closed -$334K 2016
2017
Q4
$334K Sell
10,497
-601
-5% -$20.6K ﹤0.01% 855
2017
Q3
$415K Buy
+11,098
New +$378K ﹤0.01% 799

Other funds holding LMAT

CIBC Private Wealth Group's LMAT Position: Q4 2025 in Review

CIBC Private Wealth Group reduced its LeMaitre Vascular (LMAT) stake by 22% in Q4 2025, selling an estimated $4.99K and leaving 202 shares worth $16.4K. The position accounts for ﹤0.01% of the portfolio, ranked #2243.

CIBC Private Wealth Group first reported a position in LMAT in Q3 2017 and has held it in 10 quarters since. The position peaked at $415K in Q3 2017. 297 funds tracked by Wall St. Rank hold LMAT as of Q4 2025.

  • CIBC Private Wealth Group held 202 shares of LeMaitre Vascular worth $16.4K as of Q4 2025.
  • CIBC Private Wealth Group sold 58 LeMaitre Vascular shares in Q4 2025, an estimated $4.99K.
  • LeMaitre Vascular made up ﹤0.01% of CIBC Private Wealth Group's portfolio in Q4 2025, its #2243 holding.
  • CIBC Private Wealth Group first reported a position in LeMaitre Vascular in Q3 2017 and has held it in 10 quarters since.
  • CIBC Private Wealth Group's LeMaitre Vascular position peaked at $415K in Q3 2017.
  • 297 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q4 2025.

Based on CIBC Private Wealth Group's 13F filing for Q4 2025, filed 12 Feb 2026.